home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

FDA Requirements for Device Labeling: Development, Contents, Distribution, and Changes - Webinar by GlobalCompliancePanel

 
  November 23, 2013  
     
 


GlobalCompliancePanel, Online Training, 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA
2013-12-05


Overview: Marketing wants to entice customers to buy your product instead of your competitor's! A common method is to make the labeling as eye-catching as possible. 

Be careful! You need to know what information can (and more importantly) CANNOT be present on the labeling. This presentation provides comprehensive knowledge of labeling development and subsequent control. FDA requirements and expectations regarding labeling contents will be covered, as will recommended practices to assure substantial compliance. 

Areas Covered in the Session:Prescription Device Labeling
Misbranding, False Or Misleading Labeling
Approval
Issuance
Label Integrity
Label Inspection
Contractor-Produced Labels As A Linkage With Purchasing Controls
Retention
When a labeling change requires a new submission

Who Will Benefit: This webinar is designed for those who perform, supervise, manage, audit, or oversee the creation, approval, control of labels and labeling:Regulatory Affairs management
Document Control (label generation) professionals
Design Control professionals
Quality Assurance professionals
Sales/marketing management

 

 
 
Organized by: GlobalCompliancePanel
Invited Speakers:
Jeff Kasoff, RAC, CQM, is the Director of Quality at Medivators, a leading manufacturer of consumables and instrumentation in the endoscopy field. Among his responsibilities is oversight of the document control system. In his 20+ years of Quality and Regulatory management, Jeff has implemented and overseen document control systems at all sizes of company, from startup to $100 million in revenue. Over that time, he has also been primary liaison with FDA inspectors and notified body auditors. Jeff received his regulatory affairs certification in 1996, and his certified quality management certification in 2013.
 
Deadline for Abstracts: 2013-12-05
 
Registration:
Contact Information:
NetZealous LLC,
DBA GlobalCompliancePanel 
161 Mission Falls Lane,
Suite 216, Fremont, CA 94539, USA          
USA Phone:800-447-9407
Fax: 302-288-6884
webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com


E-mail: support@globalcompliancepanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.